{{'Search' | translate}}
 

PE Rat Anti-Mouse Ly-6A/E Clone E13-161.7 (RUO)

PE大鼠抗小鼠Ly-6A / E克隆E13-161.7(RUO)

Company: BD
Catalog#: 553336
Bio-protocol()
Company-protocol()
Other protocol()

In vivo BrdU Incorporation Assay for Murine Hematopioetic Stem Cells
Author:
Date:
2013-11-05
[Abstract]  Bromodeoxyuridine (BrdU) is a thymidine analog that is incorporated into DNA during the S-phase of the cell cycle. As such, BrdU incorporation can be used to quantify the number of cells that are in S-phase in the time period during which BrdU is available. The following protocol describes an in vivo BrdU incorporation assay as a measure of cell proliferation in adult murine hematopioetic stem cells (HSCs). Specifically, BrdU incorporation was analyzed for long-term HSCs (LT-HSCs, Lin-Sca-1+c-Kit+CD34-CD135-), Short-term HSCs (ST-HSCs, Lin-Sca-1+c-Kit+CD34+CD135-) and multipotent progenitors (MPPs, Lin-Sca-1+c-Kit+CD34+CD135+) population.
[摘要]  溴脱氧尿苷(BrdU)是在细胞周期的S期期间掺入DNA的胸苷类似物。 因此,BrdU掺入可用于定量在BrdU可用的时间段内处于S期的细胞的数量。 以下方案描述了体内BrdU掺入测定作为成体鼠造血干细胞(HSC)中细胞增殖的量度。 具体地,分析BrdU掺入的长期HSC(LT-HSC,Lin-Sca-1 + c-Kit + CD34 - CD135 - ),短期HSC(ST-HSC,Lin-Sca-1 + c-Kit + CD34 和多能祖细胞(MPP,Lin-Sca-1 + c-Kit + CD34 + > CD135 + )群体

Comments